The Dysphagia Oral Nutritional Supplement industry trends have evolved significantly over the past 18 months, driven by innovation and expanding healthcare needs. Strategic partnerships have gained traction, with key players like Nestlé Health Science collaborating with digital health platforms to integrate AI-driven patient monitoring tools for personalized nutrition plans. In M&A activity, Abbott acquired a niche provider of texture-modified oral supplements, enhancing its portfolio to address complex swallowing disorders. Product launches highlight a shift toward functional ingredients, such as GlucoTrust’s recent introduction of a high-protein, low-sugar formula tailored for post-acute care patients. Regulatory updates, including the FDA’s revised guidelines on labeling clarity for caregivers, have spurred compliance-driven reforms across manufacturers. Meanwhile, consumer trends reflect heightened demand for home-delivered solutions, accelerated by telehealth adoption. Funding rounds remain robust, with NutriPharma securing $20M in Series B financing to scale its dysphagia-friendly enteral nutrition line into emerging markets. These developments underscore a forward-looking industry prioritizing accessibility, personalization, and technological synergy.